Cargando…
High EZH2 Protein Expression Is a Poor Prognostic Predictor in IDH1 R132H-Negative Gliomas
Accumulating data indicates that enhancer of zeste homology 2 (EZH2) and isocitrate dehydrogenase 1 (IDH1) are implicated in promoting tumourigenesis in a myriad of malignancies including gliomas. We aimed to determine the immunoexpression of EZH2 in gliomas and its correlation with clinicopathologi...
Autores principales: | Wong, Yin Ping, Che Abdul Aziz, Roziasyazni, Noor Aizuddin, Azimatun, Mohd Saleh, Muhamad Fakhri, Mohd Arshad, Roslina, Tan, Geok Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600772/ https://www.ncbi.nlm.nih.gov/pubmed/36292072 http://dx.doi.org/10.3390/diagnostics12102383 |
Ejemplares similares
-
Cost volume profit analysis for full paying patient services in Malaysia: A study protocol
por: Mohd Fadzil, Malindawati, et al.
Publicado: (2023) -
Association of The IDH1 C.395G>A (R132H) Mutation with Histological Type in Malay Brain Tumors
por: Yusoff, Abdul Aziz Mohamed, et al.
Publicado: (2016) -
IDH-1(R132H) mutation status in diffuse glioma patients: implications for classification
por: Wang, Peng-fei, et al.
Publicado: (2016) -
Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016) -
R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition
por: Sears, Thomas K., et al.
Publicado: (2022)